Li Sen, Jin Shuna, Song Chengwu, Chen Chang, Zhang Yang, Xiang Yi, Xu Yong, Feng Yulin, Wan Qian, Jiang Hongliang
Tongji School of Pharmacy, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei 430030, China.
Department of Pharmacy, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei 430030, China.
J Ethnopharmacol. 2016 Jan 11;177:10-8. doi: 10.1016/j.jep.2015.11.017. Epub 2015 Nov 14.
Alismatis rhizoma (AR), a Traditional Chinese Medicine with lipid-regulating properties, is usually used to treat hyperlipidemia. Lysophosphatidylcholines (Lyso PCs) play a crucial role in lipid metabolism disorders. In this study, the triterpene fraction purified from boiling water extract of AR was evaluated for its lipid lowering activity using mice with high-fat diet (HFD) induced hyperlipidemia. The metabolic changes of individual Lyso PCs treated with the triterpene fraction were detected by ultra-high performance liquid chromatography-triple quadrupole-linear ion trap mass spectrometer (UHPLC-QTRAP-MS/MS).
HFD induced hyperlipidemia mice were administrated with triterpene and non-triterpene fractions at doses of 180, 360 and 720 mg/kg body weight/day for 4 weeks, respectively. Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and atherogenic Index (AI) in mice serum were measured. The chemical components in the lipid-lowering fraction were characterized by ultra-high performance liquid chromatography-quadrupole time of flight tandem mass spectrometry (UHPLC-QTOF-MS/MS). The changes of Lyso PC in the serum of mice treated with the lipid-lowering fraction were quantified by UHPLC-QTRAP-MS/MS.
A total of 18 alisol derivatives were identified in the triterpene fraction. The hyperlipidemia mice treated with the triterpene fraction showed a significant decrease in serum TC, LDL-C and AI after continuous consumption of HFD for 4 weeks. The results also showed that 27 serum Lyso PCs in mice fed with HFD were down-regulated, and 19 were up-regulated. The abnormal serum level of Lyso PCs associated with hyperlipidemia was intervened by the alisol derivatives, with increase of unsaturated Lyso PCs and decrease of saturated ones.
The study demonstrated for the first time that triterpenes from the AR extract can lower serum lipid level in HFD induced hyperlipidemia mice. These metabolism changes of Lyso PCs could further improve our understanding of the potential mechanism of lipid lowering effect of AR.
泽泻(Alismatis rhizoma,AR)是一种具有调节血脂特性的传统中药,常用于治疗高脂血症。溶血磷脂酰胆碱(Lyso PCs)在脂质代谢紊乱中起关键作用。在本研究中,使用高脂饮食(HFD)诱导的高脂血症小鼠,对从AR沸水提取物中纯化得到的三萜组分的降脂活性进行了评估。采用超高效液相色谱-三重四极杆-线性离子阱质谱仪(UHPLC-QTRAP-MS/MS)检测经三萜组分处理后各Lyso PCs的代谢变化。
将HFD诱导的高脂血症小鼠分别以180、360和720 mg/kg体重/天的剂量给予三萜组分和非三萜组分,持续4周。检测小鼠血清中的总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和动脉粥样硬化指数(AI)。采用超高效液相色谱-四极杆飞行时间串联质谱仪(UHPLC-QTOF-MS/MS)对降脂组分中的化学成分进行表征。通过UHPLC-QTRAP-MS/MS对经降脂组分处理的小鼠血清中Lyso PC的变化进行定量分析。
在三萜组分中总共鉴定出18种泽泻醇衍生物。连续4周给予HFD后,用三萜组分处理的高脂血症小鼠血清TC、LDL-C和AI显著降低。结果还显示,喂食HFD的小鼠血清中有27种Lyso PCs下调,19种上调。泽泻醇衍生物干预了与高脂血症相关的Lyso PCs异常血清水平,使不饱和Lyso PCs增加,饱和Lyso PCs减少。
本研究首次证明,AR提取物中的三萜类化合物可降低HFD诱导的高脂血症小鼠的血清脂质水平。Lyso PCs的这些代谢变化可能会进一步增进我们对AR降脂作用潜在机制的理解。